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The enzyme TcpG is a periplasmic protein produced by the
Gram-negative pathogen Vibrio cholerae. TcpG is essential
for the production of ToxR-regulated proteins, including
virulence-factor pilus proteins and cholera toxin, and is
therefore a target for the development of a new class of
anti-virulence drugs. Here, the 1.2 A˚ resolution crystal
structure of TcpG is reported using a cryocooled crystal. This
structure is compared with a previous crystal structure
determined at 2.1 A˚ resolution from data measured at room
temperature. The new crystal structure is the first DsbA
crystal structure to be solved at a sufficiently high resolution to
allow the inclusion of refined H atoms in the model. The redox
properties of TcpG are also reported, allowing comparison of
its oxidoreductase activity with those of other DSB proteins.
One of the defining features of the Escherichia coli DsbA
enzyme is its destabilizing disulfide, and this is also present in
TcpG. The data presented here provide new insights into the
structure and redox properties of this enzyme, showing that
the binding mode identified between E. coli DsbB and DsbA
is likely to be conserved in TcpG and that the !5–"7 loop near
the proposed DsbB binding site is flexible, and suggesting that
the tense oxidized conformation of TcpG may be the
consequence of a short contact at the active site that is
induced by disulfide formation and is relieved by reduction.
Received 10 March 2012
Accepted 11 June 2012
PDB Reference: TcpG, 4dvc.
1. Introduction
The Gram-negative pathogen Vibrio cholerae is the causative
agent of cholera, a serious acute infection of the small intes-
tine caused by the ingestion of contaminated food or water.
Central to the pathogenicity of V. cholerae is the production
of a colonization pilus known as the toxin-coregulated pilus
(TCP) that facilitates the adherence of V. cholerae to host
microvilli (Peterson, 2002). The V. cholerae tcpa gene encodes
a major subunit of TCP (Chakraborty et al., 2000) and the tcpg
gene encodes a protein essential for maturation and function
of TCP proteins (Peek & Taylor, 1992). The gene product
TcpG is a thioredoxin-fold redox enzyme that catalyzes the
oxidative folding of several V. cholerae virulence factors,
including cholera toxin, and has been identified as a potential
target for the development of antibacterial compounds (Peek
& Taylor, 1992; Heras et al., 2009; Hu et al., 1997).
TcpG shares 40% sequence identity with the Escherichia
coli enzyme DsbA (EcDsbA). Like TcpG, EcDsbA is essential
for the correct folding of secreted disulfide-containing
bacterial proteins (Bardwell et al., 1991), including many
virulence factors (reviewed in Heras et al., 2009). The redox
properties of EcDsbA have been well characterized: it slowly
reduces the intermolecular disulfide bond of insulin in the
electronic reprint
classic insulin-reduction assay (Bardwell et al., 1993), it is a
strong oxidant (redox potential !122 mV at pH 7.0; Huber-
Wunderlich & Glockshuber, 1998) and it is re-oxidized by its
partner protein E. coli DsbB and cofactor ubiquinone (UQ1)
in the bacterial inner membrane (Bardwell et al., 1993; Inaba
& Ito, 2002). The crystal structure of EcDsbA (Martin et al.,
1993) comprises a thioredoxin fold (Martin, 1995) with an
inserted helical domain. An active-site CXXC motif that
contributes its disulfide to folding substrates is located on the
enzyme surface, surrounded by hydrophobic patches thought
to interact with unfolded or partly folded protein substrates.
A hydrophobic groove adjacent to the CXXC motif binds to
a redox-active periplasmic loop of the EcDsbB membrane
protein during re-oxidation of EcDsbA (Inaba et al., 2006).
A crystal structure of oxidized TcpG at 2.1 A˚ resolution has
previously been reported (Hu et al., 1997). The relatively flat
surface of the enzyme around the active site suggested that the
enzyme might not be suitable for the development of small-
molecule inhibitors. The properties, structures and virulence
functions of DsbA proteins from several bacterial organisms
have been characterized, revealing a spectrum of redox
characteristics and a variety of structural modifications that
can be accommodated into the core fold (Shouldice et al.,
2011). However, the redox properties of TcpG have not been
extensively characterized. Here, we present a comprehensive
redox characterization of TcpG and report the high-resolution
crystal structure of TcpG at 1.2 A˚ resolution. This is the
highest resolution DsbA structure reported to date and the
first DsbA crystal structure to include refined H atoms.
2. Materials and methods
2.1. Cloning, expression and purification
The V. cholerae tcpg gene (accession code P_32557) was
amplified from the pTrc99A vector, a gift from R. K. Taylor
(Dartmouth Medical College). Primers TcpG forward,
50-TAC TTC CAA TCC AAT GCG GCT CAA TTT AAA
GAAGG-30, and TcpG reverse, 50-TTATCC ACT TCC AAT
CCTACT TCAGCG TCAGCAGG-30, were used and were
compatible with ligation-independent cloning. The PCR
product was then inserted into a modified pET-21a vector
encoding an N-terminal His6 tag followed by a tobacco etch
virus (TEV) protease-recognition site with an additional three
amino acids encoded (Ser, Asn and Ala) before the gene
sequence. The amplified gene contained two variants
compared with the sequence in the UniProt sequence data-
base (accession code P_32557): Arg134His and Val164Ala
(numbering is for the mature protein after cleavage of the
signal sequence). The Arg134His mutation was introduced
during subcloning from pTrc99A into pET-21a. The Val164Ala
mutation was present in the original pTrc99A vector and may
represent an error in the database.
Competent E. coli BL21 (DE3) pLysS cells were
transformed with the plasmid containing the tcpg gene and
transformed cells were used for protein expression by auto-
induction (Studier, 2005). Bacterial cultures were pelleted by
centrifugation and the cell pellets were lysed in 50 ml lysis
buffer (per litre of cell culture) consisting of 25 mM HEPES
pH 7.5 (Biochemicals, Australia), 150 mM NaCl (Amresco,
USA), 0.5% Triton X-100 (Chem-Supply, USA), EDTA-free
protease-inhibitor cocktail (100 U; Roche, USA) and DNAse
(100 U; Roche, Australia). The sample was sonicated and cell
debris was removed by centrifugation. His6-tagged TcpG was
purified by metal-affinity chromatography using TALON resin
(Clontech, Australia; 4 ml per litre of original cell culture).
The resin was washed extensively with 25 mM HEPES,
150 mM NaCl, 20 mM imidazole (Amresco, USA) pH 7.5 and
eluted with 25 mM HEPES, 150 mM NaCl, 500 mM imidazole
pH 7.5. To remove the His6 tag, 10 ml 1 mg ml
!1 purified
TcpG was incubated with 100 ml 1 mg ml!1 recombinant His-
tagged TEV protease (Blommel & Fox, 2007) and dialyzed
against 25 mM HEPES, 150 mM NaCl pH 7.0 at 277 K for
48 h. After dialysis, the TEV-treated protein sample was
passed over TALON resin (4 ml) again to separate the His6-
tagged components from the cleaved TcpG. The protein was
further purified by gel-filtration chromatography using a
Superdex S75 16/60 column equilibrated with 10 mM HEPES,
150 mM NaCl pH 6.8 on an A¨KTA FPLC (GE Healthcare,
USA).
Peak fractions containing TcpG were pooled, concentrated
to 500 mM, oxidized by the addition of copper(II) 1,10-
phenanthroline (final concentration 1.7 mM) and incubated
for 1 h at 277 K. The oxidizing agent was removed from the
TcpG using a PD10 column (GE Healthcare, USA) with
elution buffer 10 mM HEPES, 0.5 mM EDTA pH 8.3. The
final purification step was anion-exchange chromatography
using a Mono Q 5/50 GL column on an A¨KTA FPLC with
a 0–500 mM NaCl gradient over 30 column volumes. Peak
fractions from the eluant were pooled and concentrated to
7 mg ml!1 in 10 mMHEPES, 40 mMNaCl, 0.5 mM EDTA pH
6.8 using an Amicon centrifugal concentrator with a 10 kDa
cutoff (Millipore). The protein concentration was measured
at 280 nm using a NanoDrop ND-1000 (NanoDrop Technol-
ogies) and the protein purity was assessed by SDS–PAGE on
a NuPAGE 4–12% bis-Tris gel (Invitrogen, Australia). The
protein concentration was determined using a NanoDrop 2000
(Thermo Fisher Scientific, USA). An extinction coefficient of
10 555M!1 cm!1 (calculated from the TcpG sequence using
ProtParam; Gasteiger et al., 2003) was used.
2.2. Crystallization and structure determination
Crystals of oxidized TcpG were grown by hanging-drop
vapour diffusion by mixing 1 ml protein solution at 7 mg ml!1
and 1 ml crystallization solution consisting of 13% PEG 4000,
100 mM MES pH 6.4, similar to the conditions used for the
2.1 A˚ resolution room-temperature TcpG crystal structure
(Hu et al., 1997). The cryoprotectant contained an additional
4% PEG 400 and a cocktail of four ligands (5,5-dibromo-
barbituric acid, 2-hydroxy-4-methylquinoline, l-phenylalanine
and 2-methoxyhydroquinone) at concentrations of 5 mM each
in 10% DMSO. Crystals were soaked in the cryoprotectant for
2 h. None of the four ligands bound to TcpG, although two
research papers
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DMSO molecules did bind. X-ray data were recorded on
the microcrystallography beamline MX2 at the Australian
Synchrotron using the Blu-Ice software (McPhillips et al.,
2002). Reflections were measured on an ADSC Quantum 315r
Detector (ADSC, Poway, USA) at a wavelength of 0.9536 A˚
(13 000.5 eV). The crystal-to-detector distance was 150 mm.
Oscillation images of 1# were collected for a total of 720
images using 2 s exposure per image. Diffraction data were
indexed and integrated with XDS (Kabsch, 2010) and were
scaled using SCALA (Evans, 2006). Phasing was performed by
molecular replacement with Phaser (McCoy et al., 2007) using
the structure of PDB entry 1bed (Hu et al., 1997). The final
model was obtained after several rounds of model building in
Coot (Emsley & Cowtan, 2004) and refinement in PHENIX
(Afonine et al., 2010). Structure validation was performed in
MolProbity (Chen et al., 2010).
Difference electron-density maps indicated evidence for
H atoms (Supplementary Fig. S11) and these were therefore
included in refinement, initially using the riding model and
finally using individual refinement (which lowered the Rfree
by a further 0.7%). The final model included the non-native
residues Ser!2, Asn!1 and Ala0 at the N-terminus that
originate from the engineered TEV cleavage site and residues
1–181 of the mature protein (without the signal sequence).
Density for the side chains of Gln2, Lys4, Gln10, Lys13, Lys52,
Gln162, Lys165 and Lys181 was relatively poor and these side
chains were refined with occupancies of 0–0.5. The crystal
structure showed signs of radiation damage, including partial
decarboxylation of several acidic residues (Burmeister, 2000);
affected side-chain atoms were refined with an occupancy of
0.8. Anisotropic refinement was used for all atoms (except for
H atoms), including 284 water molecules (H atoms were not
included on waters). In addition, two DMSO molecules and
a sulfate were modelled in the structure and refined with an
occupancy of 0.8. The sulfate was modelled because the
density was not explained by modelling a water molecule and
because the sulfate could be part of an MES molecule (MES
was used in the crystallization buffer). However, no density
was present for anything other than the modelled sulfate, so
we cannot conclude definitively that sulfate or MES is bound.
MolProbity (Chen et al., 2010) was used to evaluate the crystal
structure quality. Structural figures were prepared using
PyMOL (DeLano, 2002). The electrostatic surface figure was
generated by first using PDB2PQR (Dolinsky et al., 2007) to
determine the atomic charges for TcpG. The electrostatic
potential calculation was performed using APBS (Baker et al.,
2001) with an ionic strength of 150 mM, a protein core
dielectric constant of 2 and a solvent dielectric constant of 78.
The surface electrostatic potential of TcpG was contoured
from !3kT per electron (red) to +3kT per electron (blue)
and the solvent-accessible surface option was selected for
displaying the electrostatic surface charge within PyMOL.
Coordinates and structure factors have been deposited in the
PDB (entry 4dvc) and image files have been deposited in
DIMER (http://xr-diffraction.imb.uq.edu.au/).
2.3. Preparation of EcDsbB and ubiquinone 1
The plasmid pQE-70 harbouring EcDsbB was a gift from
Professor James Bardwell (University of Michigan). EcDsbB
was expressed and purified as described previously (Bader et
al., 1998) with minor modifications to the buffer compositions.
For cell lysis, a 1$ PBS buffer solution (137 mMNaCl, 2.7 mM
KCl, 100 mM Na2HPO4, 2 mM KH2PO4) with 50 U DNase
and 50 U protease inhibitor per litre of culture was used and
the cell pellets were homogenized using a 50 ml syringe.
Membrane-protein solubilization was performed in 1$ PBS
buffer and 1% dodecyl-!-d-maltoside (!-DDM; Affimetrix,
USA).
To prepare ubiquinone 1 (UQ1), a 0.85 mM solution of
2,3,4-trimethoxy-6-methyl-5-prenylphenol (225 mg in 2 ml
100% ethanol) was diluted with 10 ml water and an excess of
FeCl3 (8.5 mM) was added. The mixture was stirred at room
temperature for 2 h and then extracted with three 10 ml
portions of ethyl acetate. The organic extracts were pooled
and washed with three portions of brine (5 ml of saturated
NaCl/water solution) to give UQ1 as a pure product (220 mg,
>95%). Physicochemical data for UQ1 were in agreement with
the literature (Liang & Fener, 2004).
2.4. Redox-potential measurements
Oxidized TcpG (2 mM) was incubated in fully degassed
buffer consisting of 100 mM sodium phosphate, 1 mM EDTA
pH 7.0 containing 1 mM oxidized glutathione (GSSG; Sigma–
Aldrich, USA) and a range of reduced glutathione (GSH)
concentrations (0.1 mM–2 mM) for 24 h at room temperature.
After incubation, the reactions were stopped with 10%
trichloroacetic acid (TCA) and the precipitated protein pellets
were collected by centrifugation at 14 000 rev min!1 for
10 min at 277 K. The pellets were washed with 100% ice-cold
acetone and dissolved in a buffer consisting of 50 mM
Tris–HCl pH 7.0, 1% SDS, 4 mM 4-acetamide-40-maleimidyl-
stilbene-2,20-disulfonate (AMS) to label the free thiols.
Separation of the reduced and oxidized forms was performed
on a NuPAGE 12% bis-Tris gel (1.0 mm thick, 12-well;
Invitrogen, Australia). The gel was stained with Coomassie
Brilliant Blue and scanned: the relative intensity of the
reduced and oxidized forms was analyzed using ImageJ v.1.42q
(Abramoff et al., 2004). The fraction of the reduced protein
was plotted against the ratio [GSH]2/[GSSG], and the equi-
librium constant Keq was calculated using the equation
R ¼ ½GSH'
2
½GSSG'
!
Keq þ
½GSH'2
½GSSG'
" #
; ð1Þ
where R is the fraction of reduced protein at equilibrium. The
standard redox potential was calculated using the Nernst
equation,
E0
0 ¼ E00GSH=GSSG !
RT
nF
lnKeq; ð2Þ
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where E00GSH/GSSG is the standard potential of !240 mV
(Gilbert, 1995), R is the universal gas constant
8.314 J K!1 mol!1, T is the absolute temperature in kelvin, n is
the number of electrons transferred, F is the Faraday constant
9.648 $ 104 C mol!1 and Keq is the equilibrium constant.
2.5. Melting-temperature measurements
Thermal unfolding was performed by measuring the CD
spectrum on a J-810 spectropolarimeter (Jasco, USA).
Unfolding of reduced or oxidized TcpG was induced by
increasing the temperature from 298 to 368 K with a heating
rate of 1 K min!1. For both proteins, the conditions used were
10 mM protein in 100 mM sodium phosphate and 1 mM EDTA
pH 7.0. The redox state of the oxidized protein was verified by
Ellman’s assay. Thermal unfolding measurements of reduced
TcpG were performed in the presence of 0.75 mM DTT.
Unfolding was monitored by circular-dichroism measurements
and was analysed using Spectra Manager (Jasco, USA). Three
replicates were measured for each of the reduced and oxidized
enzymes. Thermal unfolding was calculated using a two-state
model (Pace et al., 1998),
y ¼
ðyf þmfTÞ þ ðyu þmuTÞ $ exp
!!Hm
RT
$ T ! Tm
PTm
$ %
1! exp !!Hm
RT
$ T ! Tm
PTm
$ % ;
ð3Þ
where y is the observed far-UV circular-dichroism signal at
221.5 nm for oxidized protein and at 219.5 nm for reduced
protein, yf is the intercept for the folded protein, mf is the
slope of the pre-translational baseline, yu is the intercept for
the unfolded protein, mu is the slope of the post-translational
baseline, T is the temperature, Tm is the midpoint of the
thermal unfolding curve and !Hm is the enthalpy change for
unfolding at Tm.
2.6. Insulin-reduction assay
The protein disulfide reductase activity of TcpG was
measured in vitro using the insulin-reduction assay in the
presence of DTT (Holmgren, 1979). 10 mM EcDsbA (as a
positive control) or 10 mM TcpG were mixed with buffer
consisting of 100 mM sodium phosphate, 2 mM EDTA,
0.33 mM DTT. 0.131 mM insulin was added immediately
before measurements were made. Insulin comprises an A and
a B chain connected by two disulfide bonds. Reduction of the
disulfide bonds leads to precipitation of the insoluble B chain,
and this can be followed as an increase in optical density at
650 nm. The solutions were monitored at 30 s intervals over a
period of 80 min on a Cary 50 UV–visible spectrophotometer
(Varian).
2.7. Motility assay with complemented dsbA! mutants in
E. coli
E. coli strains JCB570 (wild type) and JCB571 (dsbA!
mutant) were kindly provided by Professor James Bardwell
(University of Michigan). JCB571 was transformed chemically
(Chung & Miller, 1988) with the gene encoding tcpg (without
the Arg134His mutation) cloned into a pTrc vector. Motility
assays were performed essentially as described previously
(Macnab, 1986) in M63 minimal medium containing agar
(0.3%) supplemented with each essential amino acid except
for cysteine and cystine (40 mg ml!1). All strains (JCB570,
JCB571 and JCB571pvcdsbA) were grown as streak cultures
overnight on LB–agar plates at 310 K. Motility assays were
performed in triplicate using single colonies from the over-
night plate, which were inoculated by stabbing the centre of
the M63 soft agar plate. Plates were incubated for 7–12 h and
the diameter of the zone of swarming was measured manually.
2.8. Peptide-oxidation assay
The peptide CQQGFDGTQNSCK, with a 1,4,7,10-tetra-
azacyclododecane-1,4,7,10-tetraacetic acid (DOTA) group
amide-coupled to the N-terminus and a methylcoumarin
amide-coupled to the "-amino group of the C-terminal lysine,
was purchased from AnaSpec. The lyophilized peptide was
resuspended in 100 mM MES pH 6 at a concentration of
+1 mM. Europium trifluoromethanesulfonate was dissolved
to a concentration of 100 mM in 100 mM MES pH 6. The
europium was added to the peptide sample to a molar ratio of
3:1 and then incubated for 5 min at room temperature. Tris-(2-
carboxyethyl)phosphine hydrochloride (TCEP) was added to
a 5:1 molar ratio compared with peptide and then incubated
for 5 h at 310 K.
Reverse-phase HPLC was run on a Waters preparative
liquid-chromatography system. A 250 $ 21.20 mm Phenom-
enex Luna C8(2) column with 8–10 mm particle size and 100 A˚
pore diameter was used at a flow rate of 20 ml min!1. Peptide
elution was monitored by UV absorbance at 254 nm. The
column was pre-equilibrated in 0.1% TFA. The reduced
peptide sample was brought to 0.1% TFA immediately before
loading and injection. The peptide sample was injected onto
the column and then washed with five column volumes of
0.1% TFA. The peptide was eluted with a 0–80% acetonitrile
gradient (in the presence of 0.1% TFA) over 45 min (250 $
21.20 mm column). The purified peptide was immediately
flash-cooled in liquid nitrogen and freeze-dried. The lyophi-
lized peptide was stored at 253 K.
TcpG (Arg134His/Val164Ala) was prepared as described
above, native TcpG (Val164Ala) was expressed and purified as
described previously (Bader et al., 1998) and DsbB membrane
suspensions were expressed and purified as described in
Horne et al. (2007). EcDsbA was expressed and purified as
described in Paxman et al. (2009).
Assays were run on a Perkin Elmer Envision plate reader/
fluorimeter. A Photometric 340 narrow excitation filter and a
Cy5 620 emission filter were used, with a 100 ms delay before
reading and a 400 ms reading time. 384-well Perkin Elmer
White OptiPlate-384 plates were used. Prior to commencing
the assay, 25 ml solutions consisting of 780 nM DsbB (in
membrane suspension), 20–40 nM TcpG in 50 mM MES,
50 mM NaCl, 2 mM EDTA pH 5.5 were added to the plate
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wells. The assay was initiated by the
addition of 25 ml 16 mM peptide (in
50 mM MES, 50 mM NaCl, 2 mM
EDTA pH 5.5) to each well.
2.9. Ubiquinone-reduction assay
The enzyme EcDsbB oxidizes
EcDsbA in a reaction that requires
UQ1. During the reaction, UQ1 is
reduced by EcDsbB and this can be
monitored as a decrease in the absor-
bance at 275 nm. To determine whether
TcpG was a substrate of EcDsbB, we
followed the reduction of UQ1 using
a Varian Cary 50 UV–visible spectro-
photometer. For the assay, 30 mM
reduced TcpG was mixed with 30 mM
UQ1 and 40 nM purified EcDsbB in
0.1% !-DDM, 50 mM Tris, 100 mM
NaCl pH 8.0 at 303 K. Reduced
EcDsbAwas used in place of TcpG as a
positive control reaction. As negative
controls, TcpG was either mixed with
EcDsbB in the absence of UQ1 or
mixed with UQ1 in the absence of
EcDsbB and the reactions were started
immediately after mixing. The initial
rate of reaction was analyzed in
GraphPad Prism v.5.0d (GraphPad
Software, La Jolla California, USA)
using the one-phase exponential decay
equation, giving a calculated rate
constant K with standard error. Three
replicates were measured using the
same batches of TcpG, EcDsbA and
EcDsbB.
3. Results
3.1. High-resolution structure of TcpG
We measured high-resolution data
from a cryocooled crystal of TcpG that
had been cryoprotected in a solution
containing DMSO. The crystal structure
was solved by molecular replacement
using the previously determined room-
temperature crystal structure of TcpG
at 2.1 A˚ resolution (PDB entry 1bed;
Hu et al., 1997; Table 1). The new TcpG
crystal structure (PDB entry 4dvc) was
refined to a resolution of 1.2 A˚ and
shows the typical DsbA topology of a
thioredoxin fold comprising a CXXC
active-site motif (Fig. 1) with an inserted
helical domain.
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Table 1
X-ray data-collection and refinement statistics for TcpG.
Values in parentheses are for the highest resolution shell. Except for theMolProbity analysis, statistics for
1bed are those reported previously (Hu et al., 1997) and those for the PDB_REDO re-refined 1bed-final
were taken from the PDB_REDO website (Joosten et al., 2012).
1bed 1bed-final 4dvc
Data collection
Wavelength (A˚) 1.5418 0.95369
Resolution range (A˚) 40–2.0 (2.07–2.00) 64.3–1.2 (1.26–1.20)
Space group C2221 C2221
Unit-cell parameters (A˚, #) a = 64.0, b = 91.5,
c = 64.8,
" = ! = # = 90
a = 62.65, b = 89.52,
c = 64.26,
" = ! = # = 90
No. of molecules in asymmetric unit 1 1
Observed reflections 60945 793759 (104951)
Unique reflections 12974 (681) 56674 (8105)
Rmerge 0.062 (0.341) 0.103 (1.11)
Rp.i.m. — 0.029 (0.319)
Completeness (%) 98.2 (91.7) 99.8 (98.7)
hI/$(I)i 23.5 (3.4) 18.0 (3.1)
Multiplicity 5.7 (2.9) 14.0 (12.9)
Refinement
Resolution (A˚) 20–2.1 (2.15–2.10) 52–2.0 (2.05–2.00) 32.1–1.2 (1.23–1.20)
R factor 0.205 (0.277) 0.175 (0.253) 0.119 (0.194)
Rfree† 0.241 (0.368) 0.201 (0.295) 0.139 (0.194)
No. of atoms
Protein [including H] 1385 1454 1489 [2976]
Waters 52 252 284
DMSO — — 2 $ 8
Sulfate — — 1 $ 5
B factors (A˚2)
Wilson 31 10.0
Protein/water/DMSO/sulfate 38.2 (all atoms) 17.1 15.0/29.3/32.4/25.0
R.m.s.d. from ideal geometry
Bonds (A˚) 0.007 0.011 0.007
Angles (#) 1.2 1.2 1.2
MolProbity analysis
Ramachandran favoured/outliers (%) 96.6/0.6 97.8/0.0 98.9/0.0
Residues with bad angles (%) 1.66 0.55 0.0
Poor rotamers (%) 3.6 3.2 0.0
Clashscore [percentile] 10.95 [78th] 6.29 [95th] 2.48 [97th]
MolProbity score [percentile] 2.19 [58th] 1.78 [87th] 1.03 [98th]
† Rfree was calculated from 10% (931 reflections) and 3.5% (2000 reflections) of the diffraction data for 1bed and 4dvc,
respectively. These were selected randomly and excluded from refinement.
Figure 1
Active site of TcpG. The modelled Cys30, Pro31, His32 and Cys33 residues of the CXXC active-site
motif are shown in stick representation (H atoms were removed for clarity). The 2Fo ! Fc map was
created using FFT in the CCP4 suite (Winn et al., 2011) and is contoured at 1.0$. Although the
protein was crystallized in the oxidized form, the structure was modelled with a partial disulfide
bond (i.e. a mixture of oxidized and reduced cysteines for Cys30 and Cys33). Reduction of disulfide
bonds is often observed after X-ray exposure of crystals (Burmeister, 2000; Shimizu et al., 2007),
especially for redox-active cysteines such as those in thioredoxin and DSB proteins (Roberts et al.,
2005; Rozhkova et al., 2004).
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Superimposition of the cryocooled high-resolution struc-
ture and the room-temperature structure 1bed solved at 2.1 A˚
resolution gives a root-mean-square deviation (r.m.s.d.) of
0.64 A˚ for 172 C" atoms. Although the overall folds are
identical, there are localized differences in the structure. For
example, the short loop comprising residues 161–167 that
connects strand !5 to the C-terminal helix "7 adopts different
conformations in the two structures (Fig. 2). The equivalent
loop in EcDsbA is six residues longer than in TcpG; it is also
flexible and forms one edge of a hydrophobic groove that
binds the periplasmic loop of EcDsbB. The !5–"7 loop is
relatively disordered in the 1bed structure, with most of the
side chains not included in the model. The recently re-refined
1bed structure (1bed_final from the PDB_REDO team;
Joosten et al., 2012) is a much improved model (Table 1), but
the loop remains poorly ordered, especially residues Gln162,
Ser164, Val164 and Lys165. The conformation of the loop is
similar in 1bed and 1bed_final. By comparison, the equivalent
loop in the high-resolution structure is relatively well ordered,
with excellent density for the main-chain atoms and almost
all side chains modelled. The main-chain conformation of the
loop differs between the 4dvc and 1bed TcpG structures, with
an r.m.s.d. of 0.65 A˚ for the C" atoms of residues 161–167.
These results suggest that the C-terminal !5–"7 loop of TcpG
is more flexible than the rest of the structure and this is likely
to be important for its role in binding the periplasmic loop of
DsbB. This finding supports the conclusions of Horne and
coworkers that this loop is mobile in solution (Horne et al.,
2007) as shown by relatively few NOE constraints and because
proteolytic cleavage was found to occur first at Lys165 in the
!5–"7 loop. Furthermore, NMR dynamic studies of TcpG
(Horne et al., 2007) identified a domain-hinge motion unique
to reduced TcpG. This hinging motion was thought to favour
opening of the !5–"7 loop to facilitate binding of the DsbB
periplasmic loop in the hydrophobic groove of the reduced
protein (Horne et al., 2007).
The N-terminal residues also exhibit local differences
between the high-resolution TcpG structure and 1bed, as can
be seen in the distribution of r.m.s.d. values for main-chain
atoms (Fig. 2b; r.m.s.d. of 1.0 A˚ for the 19 N-terminal C"
atoms). Similarly, the r.m.s.d. is 1.4 A˚ for the 19 N-terminal C"
atoms of the high-resolution TcpG structure in comparison
with the NMR structure of reduced TcpG; PDB entry 2ijy;
Horne et al., 2007) and 2.1–2.5 A˚ for comparison with EcDsbA
(PDB entry 1fvk, chains A and B; Guddat et al., 1997). Clearly,
the N-terminus of TcpG, like that of many proteins, is rela-
tively flexible, even though it adopts the same overall topology
and secondary structure in each of these structures.
3.2. Small-molecule binding sites
DMSO was included in the cryoprotectant solution used for
TcpG crystal soaking prior to diffraction data collection. The
resulting electron-density map revealed two regions that bind
DMSO (which we modelled as DMSO1 and DMSO2) and a
binding site at the N-terminus that was modelled as a sulfate.
DMSO1 and DMSO2 bind in two pockets, as shown in
Fig. 3(a). DMSO1 binds in a cavity between the thioredoxin
and helical domains of TcpG on the opposite face of the
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Figure 2
Comparison of the 1.2 and 2.1 A˚ resolution TcpG structures. (a) The two
structures were superimposed, with the 1.2 A˚ resolution structure shown
in yellow and the 2.1 A˚ resolution structure 1bed shown in cyan. The
sulfurs of the active-site cysteines are shown as orange spheres. The
boxed region highlights the conformational variation between the two
crystal structures in the region of the !5–"7 loop. The positions of the two
mutated residues (Arg134His and Val164Ala) in the polypeptide chain
are highlighted in red. (b) Plot of C"-atom r.m.s.d. for the comparison of
the 1.2 A˚ resolution TcpG structure with the 2.1 A˚ resolution crystal
structure 1bed (calculated using the SUPERPOSE program in the CCP4
suite; Winn et al., 2011). The plot was prepared using GraphPad Prism
v.5.0d (GraphPad Software, La Jolla, California, USA). The plot
highlights that the largest differences between the two structures are at
the N- and C-termini and in the !5–"7 loop.
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molecule to the active-site surface. The DMSO1 pocket is
formed by the side chains of Glu37, Lys55, Tyr73, Glu82,
Asp83 (Fig. 3b) and Val86 (not shown). DMSO2 binding is not
as well defined and the density suggests more than one binding
mode. Residues forming the DMSO2 site are contributed by
the N- and C-termini of TcpG: Ser19, Pro20, Asn154 and
Lys181 (Fig. 3c). Additional density was observed at a crystal
contact point including interactions with the N-terminal
engineered residues Ser!2 and Asn!1. This density was
modelled as a sulfate (Fig. 3a).
3.3. TcpG is more active than EcDsbA in the insulin-
reduction assay
We tested TcpG for its ability to catalyze the reduction of
insulin in the classic redox-activity assay. Insulin comprises
two chains, A and B, linked by two disulfide bonds. The B
chain is insoluble and reduction of the disulfide bonds leads to
B-chain precipitation, which can be monitored as an increase
in absorbance at 650 nm. Under the standard assay conditions,
the disulfide isomerase E. coli DsbC (EcDsbC) catalyzes
insulin reduction by DTT. This results in precipitation of the
B chain and a consequent increase in the OD650 which is
measurable after 7 min (Shevchik et al., 1994). EcDsbA-
mediated catalysis was slower than that mediated by EcDsbC,
with the increase in OD650 being measurable after 15 min
(Wunderlich et al., 1993). TcpG-mediated DTT reduction of
insulin occurs relatively quickly, being measurable after 7 min
(Fig. 4a). Therefore, in this assay under these conditions the
activity of TcpG is more similar to that of the bacterial
disulfide isomerase EcDsbC than to that of the bacterial
dithiol oxidant EcDsbA.
3.4. TcpG is as oxidizing as EcDsbA
When it was first characterized, EcDsbA was described
as the most oxidizing thioredoxin-like protein, with a redox
potential of !122 mV (Huber-Wunderlich & Glockshuber,
1998). By comparison, the disulfide-reducing protein E. coli
thioredoxin has a redox potential of !270 mV (Aslund et al.,
1997). Compared with EcDsbA, the redox-potential values of
other DsbA proteins vary from more reducing (e.g. "-DsbA1
fromWolbachia pipientis, E00 = !163 mV; Kurz et al., 2009) to
more oxidizing (e.g. NmDsbA3 from Neisseria meningitidis,
E00 = !89 mV; Vivian et al., 2009). We determined the stan-
dard redox potential of TcpG relative to the redox potential of
GSH/GSSG (!240 mV). The equili-
brium constants were determined from
the calculated fraction of reduced TcpG
at different concentrations of [GSH]2/
[GSSG] (Fig. 4b). From these data, the
Keq for TcpG was 7.7 , 0.03 $ 10!5 M
and the corresponding redox potential
was !116 mV at pH 7.0. Thus, in the
spectrum of redox potentials for thio-
redoxin-fold proteins TcpG is relatively
oxidizing, with a redox-potential value
similar to that of EcDsbA.
The active-site cysteine of EcDsbA
has an unusually low pKa of +3.5
(Nelson & Creighton, 1994), which is
thought to be important for redox
activity since the thiolate form of the
reduced side chain is favoured at
physiological and acidic pH. We made
several attempts to measure the pKa of
the active-site cysteine of TcpG using a
range of different buffers. However, we
found that reduced TcpG precipitates at
pH values of!5 and below and we were
thus unable to measure the pKa of TcpG
Cys30.
3.5. Reduced TcpG is more stable than
oxidized TcpG
TcpG contains no Trp residues and
does not exhibit intrinsic fluorescence,
unlike other DsbA proteins such as
EcDsbA. Therefore, its thermal stability
cannot be assessed using changes in
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Figure 3
Electrostatic surface of TcpG showing small-molecule binding sites. (a) The electrostatic potential is
plotted on the molecular surface of TcpG, with charge levels from !3kT/e (red) to +3kT/e (blue).
PDB2PQR was used to assign atomic charges and radii based on the PARSE force field and the
electrostatic potential calculation was performed using the APBS software (Dolinsky et al., 2004).
The two DMSO molecules and one sulfate molecule that were modelled into the electron density
are shown as space-filling models and their positions are identified with labels and arrows. A box
also highlights the bound sulfate located at a crystal contact point: a symmetry-related molecule of
TcpG (white) is shown forming part of the sulfate-binding site. (b) DMSO1 is shown with associated
2Fo ! Fc electron density contoured at 1.0$. The binding site is located between the helical and
thioredoxin domains of TcpG. Two waters are shown as red spheres: these mediate hydrogen bonds
to Lys55 and Tyr73. For clarity, Val86, which forms part of this site, is not shown. (c) DMSO2 is
shown with associated 2Fo! Fc electron density contoured at 1.0$. Nearby residues are also shown.
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intrinsic fluorescence. We investigated the relative stability of
the two redox forms of TcpG using circular dichroism (CD) by
observing changes in CD during thermal unfolding of reduced
and oxidized forms of the enzyme over the temperature range
298–368 K at pH 7.0 (Fig. 5a). The thermal transition values
calculated from these data showed that the melting tempera-
ture of reduced TcpG is higher than that of oxidized TcpG by
11 K (Tm oxidized = 346 , 0.1 K, Tm reduced = 357 , 0.3 K).
These results are in excellent agreement with previous data
for TcpG measured by differential scanning calorimetry
(Tm oxidized = 346 K, Tm reduced = 357 K; Horne et al., 2007).
The reduced form of TcpG is therefore more stable than
oxidized TcpG, indicating that disulfide formation at the active
site destabilizes TcpG. This is also the case for EcDsbA
(Huber-Wunderlich & Glockshuber, 1998), although the
difference in melting temperature is larger for TcpG than for
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Figure 5
Relative stability of reduced and oxidized TcpG and the interaction of
reduced TcpG with EcDsbB. (a) This plot shows the thermal unfolding of
TcpGmeasured in 100 mM sodium phosphate and 1 mM EDTA at pH 7.0
with 10 mM oxidized (squares) or reduced (diamonds) TcpG. (b)
Ubiquinone reduction of EcDsbB–UQ1 by TcpG. 30 mM reduced TcpG
or 30 mM EcDsbA as a positive control was mixed with EcDsbB and the
reaction was started by adding UQ1. UQ1 reduction was monitored at
275 nm. (The difference in starting absorbance arises from the differing
intrinsic fluroescence of EcDsbA and TcpG.) The data presented in (a)
and (b) are representative of three experiments.
Figure 4
Characterization of the redox properties of TcpG. (a) The disulfide-
reductase activity of TcpG was assessed using the insulin-reduction assay.
10 mM TcpG or 10 mM EcDsbA was used to catalyze the reaction in the
presence of 131 mM insulin in 100 mM sodium phosphate buffer pH 7.0,
2 mM EDTA, 330 mM DTT. The curve labelled ‘blank’ contained all
components except DsbA/TcpG. The data are representative of three
independent experiments. (b) Nonlinear fit to the fraction of reduced
TcpG at different ratios of reduced:oxidized glutathione. This fit was used
to obtain the equilibrium constantKeq and the redox potential (calculated
relative to the GSH/GSSG standard potential of !240 mV; Gilbert,
1995). The curve was fitted to the averaged data from three replicate
experiments (the mean and standard deviation of each point is shown).
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EcDsbA (!Tm TcpG = 11 K; !Tm EcDsbA = 8 K; Huber-
Wunderlich & Glockshuber, 1998). These results also highlight
that either CD or differential scanning calorimetry can be used
to accurately measure Tm for DsbA proteins which lack a
tryptophan residue.
3.6. TcpG interacts with EcDsbB
UQ1 acts as an electron acceptor in the EcDsbB–EcDsbA
reaction: EcDsbB oxidizes the active-site thiols of reduced
EcDsbA and passes the electrons to bound UQ1 (Bader et al.,
2000; Inaba & Ito, 2002). UQ1 reduction can be measured as a
change in absorbance at 275 nm. Thus, when reduced EcDsbA
is mixed with EcDsbB and UQ1 the absorbance at 275 nm
decreases rapidly, indicating a redox interaction between the
components. We found that when TcpG is used in place of
EcDsbA, UQ1 is steadily reduced and the reaction is complete
in 5 min (Fig. 5b). These findings show that TcpG can be
oxidized by the homologous EcDsbB/UQ1 system, although
the initial rate of UQ1 reduction by TcpG–EcDsbB is slower
than that by EcDsbA–EcDsbB (the rate constants are 0.4 ,
0.01 and 3.2 , 0.01 min!1, respectively).
The amino-acid sequence (98-PSPFATCDF-105) of the
EcDsbB periplasmic loop that is observed to interact with
EcDsbA in the crystal structure of the complex (Inaba et al.,
2006) is highly conserved in the V. cholerae DsbB homologue
(Supplementary Fig. S2). This conservation suggests that the
VcDsbB loop residues might interact with TcpG in the same
way that the equivalent EcDsbB residues interact with
EcDsbA. The EcDsbA–EcDsbB crystal structure (PDB entry
2hi7; Inaba et al., 2006) reveals that the EcDsbB periplasmic
loop adopts a relatively extended conformation that loops
around the active-site residue His32 of EcDsbA with a turn
centred on residue Phe101 of EcDsbB. This Phe101 residue
makes extensive interactions with the EcDsbA hydrophobic
groove (Fig. 6a). A disulfide is formed between Cys104 of
EcDsbB and Cys30 of EcDsbA (S—S distance of 2 A˚) and
backbone hydrogen-bond interactions appear to be formed
with residues in the cis-proline loop of EcDsbA (EcDsbA
Val150 O to EcDsbB Cys104 N, 3.5 A˚; EcDsbA Val150 N to
EcDsbB Cys104 O, 3.6 A˚; EcDsbA Arg148 O to EcDsbB
Phe106 N, 3.3 A˚).
To examine whether similar interactions could be formed
with TcpG, we superimposed the high-resolution crystal
structure of TcpG onto the structure of EcDsbA from the
EcDsbA–EcDsbB complex. Fig. 6(b) shows that the EcDsbB
binding mode for the PSPFATCDF residues could be adopted
but would require rotation of the side chain of TcpG active-
site residue His32 (which otherwise blocks the EcDsbB loop)
as well as movement of the !5–"7 loop (Gln162 of the TcpG
!5–"7 loop blocks the EcDsbB loop). Movement of the !5–"7
loop is possible since the loop appears to be flexible, as indi-
cated above. Moreover, the superimposed model of the DsbB
periplasmic loop supports the similar formation of an inter-
molecular disulfide (S—S distance of 3 A˚) and potential
hydrogen-bond interactions between DsbB and the cis-proline
loop of TcpG (Fig. 6c; TcpG Val148 O to EcDsbB Cys104 N,
2.7 A˚; TcpG Val148 N to EcDsbB Cys104 O, 3.1 A˚; TcpG
Thr146 O to EcDsbB Phe106 N, 3.2 A˚).
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Figure 6
Model of the interaction of TcpG with EcDsbB. (a) Surface representa-
tion of EcDsbA (white) and its interaction with the periplasmic loop of
EcDsbB 99-PSPFATCDF-106 (green stick format; Pro99 is on the far
right-hand side in this orientation). The active site of EcDsbA is coloured
orange and the His32 side chain is labelled. Thr167 from the flexible
!5–"7 loop is also labelled. This figure is derived from the crystal
structure of the E. coli DsbA–DsbB complex (Inaba et al., 2006). (b)
TcpG was superimposed onto the structure of EcDsbA from the DsbA–
DsbB complex and the overlay of the DsbB periplasmic loop is shown
using the same colour scheme as above. Gln162 from the flexible !5–"7
loop is labelled. (c) The interactions observed between E. coli DsbA and
DsbB could also occur for TcpG. TcpG residues are shown in white,
EcDsbB residues in green and potential hydrogen-bond interactions are
shown as dashed lines. The intermolecular disulfide between Cys104 of
DsbB and Cys30 of TcpG is also indicated by a dashed line.
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3.7. TcpG oxidizes cysteines in proteins and peptides
The ability of TcpG to rapidly reduce insulin disulfides
raised the question of whether TcpG is primarily an oxidant, a
reductant or an isomerase. We tested this in two ways. Firstly,
we determined whether TcpG could complement EcDsbA in a
motility assay. EcDsbA is required for the oxidative folding of
FlgI, a protein essential for producing functional flagella in
E. coli (Dailey & Berg, 1993). In the absence of EcDsbA,
E. coli are nonmotile on soft agar (Dailey & Berg, 1993).
We tested whether native TcpG (Val164Ala) was able to
complement EcDsbA in this assay and found that TcpG did
indeed restore the motility of E. coli in this assay (Fig. 7). This
indicates that TcpG, like EcDsbA, is able to act as an oxidant
to form disulfides in FlgI.
We also investigated the ability of TcpG to catalyze disul-
fide formation in an in vitro peptide-oxidation assay. We tested
both TcpG (Val164Ala) and TcpG (Arg134His/Val164Ala). In
this assay, both forms of TcpG catalyze peptide oxidation at
the same rate as EcDsbA and above the baseline rate of aerial
and nonspecific oxidation observed in the absence of enzyme
(Fig. 7). These results suggest that TcpG acts primarily as a
disulfide oxidant, like EcDsbA.
4. Discussion
V. cholerae is a dangerous human pathogen that is responsible
for outbreaks of cholera, a prevalent and problematic public
health issue in developing countries where water sanitation
is compromised. TcpG is required to correctly fold ToxR-
regulated proteins involved in V. cholerae fimbriae maturation
and the release of virulence factors (Peek & Taylor, 1992).
Inhibiting TcpG activity has therefore been suggested as a
means of developing drugs for the treatment of cholera (Hu et
al., 1997; Heras et al., 2009). Although TcpG was one of the
first DsbA proteins to be described and structurally char-
acterized, its redox properties have not previously been
reported. We have performed a comprehensive biochemical
investigation of TcpG, showing that it catalyzes insulin
reduction more rapidly than EcDsbA, that TcpG and EcDsbA
have a similar oxidizing ability and that they both possess a
destabilizing active-site disulfide.
The high-resolution TcpG crystal structure model includes
both oxidized and reduced forms, so that the two redox forms
can be compared in the region of the active site to identify
possible reasons for the characteristic destabilizing disulfide of
DsbA proteins. The crystal structure reveals that a Cys30 C!
methylene H atom is very close to the main-chain O atom
of Ser27 (2.3 A˚) in the presence of the disulfide. The
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Figure 8
Reduced and oxidized TcpG. The crystal structure of TcpG includes
models of both oxidized and reduced TcpG with H atoms included. The
presence of a disulfide may cause a steric clash between a methylene H
atom of Cys30 and a main-chain O atom of Ser27 (2.3 A˚) which is relieved
in the reduced structure (2.7 A˚).
Figure 7
TcpG catalyzes disulfide formation in vivo and in vitro. (a) JCB570 E. coli
wild-type cells are able to swarm on soft agar because they produce
functional flagella (swarming is evident as a halo around the original stab
point; left panel). In the absence of EcDsbA E. coli do not produce
functional flagella because FlgI, an essential component of flagellar
assembly, requires a disulfide bond (no swarming is evident; middle
panel). TcpG (Val164Ala) is able to complement this nonmotile
phenotype (right panel) as shown by the halo around the originial stab
point with a diameter similar to that in the left panel (right panel). (b)
Fluorescence curves representative of peptide oxidation are shown in the
presence of 80 nM TcpG (Val164Ala) (squares), 80 nM TcpG
(Arg134His/Val164Ala) (diamonds), 80 nM EcDsbA as a positive control
(circles) and no TcpG/DsbA as a negative control (triangles). All three
enzymes display a similar rate of peptide oxidation under these
conditions, which is significantly faster than the negative control.
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corresponding distance in the reduced form is 2.7 A˚ (Fig. 8).
The short contact in the oxidized form suggests the possibility
of either a C—H- - -O hydrogen bond (Derewenda et al., 1995)
or a steric clash. The contact does not seem to have the
appropriate geometry for a C—H- - -O hydrogen bond, so is
probably destabilizing. If so, this contact could contribute
to the so-called ‘tense’ conformation of DsbA proteins
(Wunderlich et al., 1993). However, this possible explanation
for the destabilizing disulfide requires confirmation by analysis
of similarly high-resolution crystal structures (<1.2 A˚, with H
atoms modelled) of both redox forms of thioredoxin-fold
proteins that do not exhibit a destabilizing disulfide (e.g.
thioredoxin or glutaredoxin). Such structures are currently not
available.
The strong insulin-reduction activity of TcpG was un-
expected. This prompted us to ask whether V. cholerae
encodes a DsbC disulfide isomerase homologue. If not, TcpG
could potentially catalyse oxidase and isomerase activities.
A BLAST (Altschul et al., 1990) search of the Vibrio B33
genome did identify a potential DsbC homologue (accession
code EE_018795). However, the sequence identity of this
putative VcDsbC to the E. coli disulfide isomerase DsbC was
only 21% using ClustalW (Thompson et al., 1994). The char-
acteristic sequence motifs of EcDsbC are a CPYC active-site
motif (CPHC in EcDsbA) and a Thr preceding the cis-Pro
loop (Val in EcDsbA). DsbC also forms a V-shaped homo-
dimer (McCarthy et al., 2000) rather than the two-domain
monomer of DsbA, which prevents interaction with DsbB
(Bader et al., 2001). In all these respects, TcpG is more like
EcDsbA than EcDsbC: it interacts with EcDsbB, it does not
form a V-shaped homodimer, it has a CPHC active site and a
Val-cis-Pro motif. We also found that TcpG, unlike DsbC, is
able to complement EcDsbA in an in vivo motility assay and
to catalyze peptide oxidation to the same extent as EcDsbA.
Taking these findings into consideration, we conclude that
the primary function of TcpG is to catalyze the oxidation of
protein cysteines.
We found that reduced TcpG is able to donate its electrons
to EcDsbB and thus can be re-oxidized. V. cholerae encodes a
DsbB (VcDsbB; accession code ZP_01976503) which shares
47% sequence identity with EcDsbB (accession code
NP_415703). Similarly, TcpG shares 40% sequence identity
with EcDsbA. Interestingly, the periplasmic loop residues of
EcDsbB that interact with EcDsbA are highly conserved in
the equivalent loop in VcDsbB. Therefore, our finding that
TcpG is oxidized by EcDsbB suggests that the mechanism by
which TcpG is oxidized in vivo will be similar to that of E. coli.
A model of the EcDsbB and TcpG complex suggests that
similar disulfide and hydrogen-bond interactions can occur.
However, for the periplasmic loop of DsbB to interact with the
TcpG hydrophobic groove in the same way that it interacts
with EcDsbA, the TcpG active-site His32 must rotate and
the !5–"7 loop must move compared with the conformation
observed in the high-resolution crystal structure. Evidence
from NMR and proteolysis experiments (Horne et al., 2007)
and now crystal structures supports the notion that the !5–"7
loop is flexible, like that of EcDsbA, and therefore it is likely
to play the same role in forming part of the binding site of
DsbB.
The structural differences between the previously reported
crystal structure of TcpG (PDB entry 1bed) and the newly
reported crystal structure (PDB entry 4dvc) could be a
consequence of the increased resolution of the new TcpG
structure, the newer refinement methods used, the different
temperatures used for diffraction data measurement, which
resulted in a 5% reduction in unit-cell volume for the 1.2 A˚
resolution structure, the presence of bound small molecules,
minor variations in the sequence, the presence of an
N-terminal His tag or a combination of these factors. It is
likely that we can rule out newer refinement methods, because
the PDB_REDO structure 1bed_final has much better
refinement statistics than 1bed (Table 1) yet shows the same
structural differences from 4dvc in the !5–"7 loop and the
N-terminus (Supplementary Fig. S3). The structural flexibility
at the !5–"7 loop is likely to have a functional role in that it
forms part of the proposed DsbB-binding site. By comparison,
the N-terminal residues form a relatively unstructured region
followed by a !-strand that interacts with !5, similar to that
in EcDsbA. The structural differences observed at the
N-terminus for 1bed and 4dvc may therefore simply reflect the
variability that is often observed at N- and C-termini.
The lack of surface definition surrounding the TcpG active
site in 1bed suggested that identification of small-molecule
binders as a starting point for inhibitor design might prove to
be difficult. However, the high-resolution TcpG structure
identified two potential DMSO-binding sites, one of which is
located in the interdomain space between the helical and the
thioredoxin domains. This result suggests that it may be
possible to discover and design small molecules that target
TcpG, opening up the possibility of the development of TcpG
inhibitors. Inhibitors of EcDsbB and the related Myco-
bacterium tuberculosis membrane protein VKOR have
recently been reported (Fru¨h et al., 2010; Dutton et al., 2010).
To date, no inhibitors of DsbA have been described. An
inhibitor that targets the region surrounding the active-site
disulfide of DsbA could act as a competitive inhibitor of
substrate or DsbB binding. An inhibitor that targets the
interdomain space might work allosterically by blocking
domain-hinge motion: NMR relaxation data for TcpG suggest
that such domain motion may support the catalytic cycle
(Horne et al., 2007). There is also indirect evidence that
allosteric binding to the reverse surface of DsbA can affect
redox activity. Thus, the Gram-positive DsbA, BdbD, binds
Ca2+ on the reverse surface, and allosteric binding of this
divalent cation changes the redox potential by 20 mV (Crow et
al., 2009).
In conclusion, our investigations have provided a high-
resolution structure of TcpG, the V. cholerae DsbA and have
defined the redox properties and interactions of this enzyme.
The inclusion of H atoms in the refined TcpG structure has
identified a possible explanation for the tense conformation of
oxidized DsbAs, but this requires confirmation using similarly
high-resolution pairs of structures from proteins that do not
have destabilizing disulfides.
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